Fluoroscopy Equipment Global Market Report 2024

The fluoroscopy equipment market size has grown strongly in recent years. It will grow from $6.27 billion in 2023 to $6.67 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be ascribed to an increase in minimally invasive procedures, a rise in the geriatric population, the broadening scope of applications in medical diagnosis, advancements in diagnostics, and a higher incidence of chronic diseases.

The fluoroscopy equipment market size is expected to see steady growth in the next few years. It will grow to $8.08 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The anticipated growth in the forecast period can be credited to the rapid expansion of ambulatory surgical centers, the increasing scope of cardiovascular interventions, a heightened emphasis on reducing radiation doses, the growing popularity of hybrid operating rooms, and integration with other imaging modalities. Noteworthy trends expected in the forecast period encompass technological innovations in imaging, advancements in imaging technology, the adoption of remote guidance and collaboration, enhanced integration and analytics of data, and a focus on ergonomics and user experience.

The anticipated growth of the fluoroscopy equipment market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting a year or longer and requiring ongoing medical attention, are on the rise. Fluoroscopy equipment proves valuable in providing real-time functional and anatomic assessments of patients while minimizing radiation exposure when contrast administration is involved. For example, a projection from the National Center for Biotechnology Information (NCBI) in January 2023 estimated that the number of individuals aged 50 years and older with at least one chronic illness would increase to 142.66 million by 2050, representing a 99.5% rise from 71.522 million in 2020. Hence, the growing prevalence of chronic diseases is a significant driver of the fluoroscopy equipment market.

The increasing incidence of gastrointestinal disorders is anticipated to contribute to the growth of the fluoroscopy equipment market. Gastrointestinal (GI) disorders, affecting any part of the gastrointestinal tract, benefit from fluoroscopy's role in diagnosis and management. Real-time X-rays allow the visualization of internal organs and their movements, particularly useful for examining dynamic processes such as swallowing, digestion, and bowel movements. A survey report by Bodibio in October 2021, covering 33 countries and 73,076 adults, revealed that 40% of respondents had a functional gastrointestinal disorder, including variations of functional dyspepsia, irritable bowel syndrome, functional constipation, among others. Therefore, the increasing prevalence of gastrointestinal disorders is a driving factor for the fluoroscopy equipment market.


Product innovation stands out as a prominent trend gaining traction in the fluoroscopy equipment market. Major players within the fluoroscopy equipment market are actively engaged in developing inventive products to fortify their market positions. An illustrative example is Fujifilm Healthcare Americas Corporation, a US-based manufacturer of diagnostic and business imaging solutions, which, in July 2022, introduced the FDR Cross. Recognized as the world’s inaugural two-in-one fluoroscopy and digital radiography system, the FDR Cross represents an advanced portable X-ray and hybrid C-arm solution tailored for medical facilities and ambulatory surgery centers (ASC). This pioneering C-arm is distinguished as the first to offer both mobile radiography and fluoroscopic imaging on a single platform, eliminating the need for additional imaging equipment during essential image-guided procedures.

Major companies operating in the fluoroscopy equipment market are directing their focus towards the development of innovative solutions, notably high-end fluoroscopy systems. Characterized by their advanced features, capabilities, and imaging quality, high-end fluoroscopy systems are sophisticated medical imaging equipment tailored for fluoroscopic procedures. A case in point is Siemens Healthineers, a Germany-based healthcare company that, in September 2021, launched ‘Luminos Impulse.’ This state-of-the-art system integrates a seamless imaging chain, extensive dose optimization, robust cybersecurity attributes, and the capacity to share detectors for radiography. The Luminos Impulse, as a fully digital system, delivers top-tier features and superior imaging, aligning with the contemporary demands of fluoroscopy and radiography.

In March 2021, Fujifilm Corporation, a Japan-based imaging and information solutions provider, acquired the diagnostic imaging business of Hitachi Ltd. for $1.41 billion (179 billion yen). This acquisition positions Fujifilm Corporation as a comprehensive provider of medical technologies, further enhancing its initiatives. Hitachi Ltd., a Japan-based X-ray company, specializes in manufacturing radiography and fluoroscopy systems.

Major companies operating in the fluoroscopy equipment market report are Hitachi Medical Corporation, Thermo Fisher Scientific Inc., Medtronic Plc., Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Terumo Corporation, Hologic Inc., Varian Medical Systems Inc., Mindray Medical International Limited, Shimadzu Corporation, Agfa-Gevaert N.V., Lepu Medical Tech Co. Ltd., Carestream Health Inc., Varex Imaging Corporation, Canon Medical Systems Corporation, Ziehm Imaging GmbH, Allengers Medical Systems Limited, Orthoscan Inc., Xoran Technologies LLC, Toshiba Medical Systems Corporation, Adani Systems Inc., Trisonics Inc.

North America was the largest region in the fluoroscopy equipment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluoroscopy equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fluoroscopy equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary products within the category of fluoroscopy equipment include fixed fluoroscopy equipment, mobile C-arms, and fixed C-arms. Fixed fluoroscopy equipment consists of a radiolucent patient examination table featuring an under-table-mounted tube, with an imaging detector positioned over the table. These systems are employed across various applications, including diagnostic and surgical procedures, and are utilized by end-users such as hospitals and diagnostic centers.


The fluoroscopy equipment research report is one of a series of new reports that provides fluoroscopy equipment market statistics, including the fluoroscopy equipment industry's global market size, regional shares, competitors with fluoroscopy equipment market share, detailed fluoroscopy equipment market segments, market trends and opportunities, and any further data you may need to thrive in the fluoroscopy equipment industry. This fluoroscopy equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fluoroscopy equipment market consists of sales of fixed and mobile fluoroscopic systems, remote-controlled systems, and patient-side-controlled systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.